• Oct. 11, 2025, 8:00 AM EDTBy Alicia Victoria…
  • Palestinians Begin Return Home As Ceasefire Takes Effect
  • Oct. 11, 2025, 8:48 AM EDT / Updated Oct. 11, 2025,…
  • Inside the scramble to save lives as deadly…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

‘Sorry, I wasn’t here to save you’: Bereaved father visits site of daughter’s Oct. 7 death

admin - Latest News - October 7, 2025
admin
5 views 25 secs 0 Comments



On the second anniversary of the Oct. 7 Hamas attacks, Eyal Eshel visited the burned-out IDF observation post where his daughter Roni and other young IDF spotters were killed. “Nobody listened to them,” he said, after playing a recording of Roni’s call for help from that day.



Source link

TAGS:
PREVIOUS
Freed Hamas hostage remembers Oct. 7
NEXT
Trekkers rescued from blizzard-struck Mount Everest
Related Post
October 3, 2025
Oct. 3, 2025, 1:56 AM EDT / Updated Oct. 3, 2025, 2:18 AM EDTBy Phil HelselLOS ANGELES — A large fire was reported Thursday night at a Los Angeles-area oil refinery, prompting a response by first responders, according to officials and video that captured the scene.Helicopter footage from NBC Los Angeles showed flames coming from two of the stacks and one other area at the Chevron refinery in El Segundo. The city of El Segundo said the event was a fire at the refinery, and “not a flaring event.” There were no evacuations ordered, it said.It was not clear if there were any injuries. Chevron did not immediately respond to a request for comment.Manhattan Beach, a neighboring coastal city in Los Angeles County, told residents that it was aware of the “unusual fire event” at the Chevron refinery, but that there was no evacuation order. The city told residents to stay inside.Video captured on social media showed a fireball appearing to erupt from the facility, and flames that lit up the horizon.“I saw this thing just go up,” one local resident whose lived in the area for eight years told NBC Los Angeles. “I never, ever fear anything. This — I got in panic mode when I saw it. I was literally in panic mode.”The oil refinery covers around 1,000 acres and has around 1,100 miles of pipelines, according to the facility’s website. It primarily refines gasoline, jet and diesel and can refine up to 290,000 barrels of crude oil per day, according to the site.California Gov. Gavin Newsom has been briefed on the situation, his office said on X.”Our office is coordinating in real time with local and state agencies to protect the surrounding community and ensure public safety,” the governor’s office said.By 11 p.m. helicopter footage from NBC Los Angeles showed firefighters working to douse a plume of flame by spraying from ladder trucks in one part of the facility, while two of the stacks also had flames coming from their tops.Phil HelselPhil Helsel is a reporter for NBC News.Jean Lee, Matthew Mulligan, Bill Feather and Todd Miyazawa contributed.
September 25, 2025
Sept. 25, 2025, 11:38 AM EDTBy Rob WileData released Thursday reflects the resilience of the U.S. economy, even as concerns about the job market and inflation persist.U.S. economic growth, or the gross domestic product (GDP), reached 3.8% in the second quarter, according to a fresh revision of the data released Thursday by the Commerce Department. That was higher than the most recent estimate of 3.3% and the strongest reading since the third quarter of 2024. The revision largely reflected stronger growth in consumer spending, which was also revised upward, from 1.6% to 2.5%. Multiple surveys show the mood among consumers remains glum — but Thursday’s spending data, plus other releases from banks, signals they remain willing to maintain their pace of purchasing. Meanwhile, new and ongoing claims for unemployment assistance fell over the past week, according to the U.S. Department of Labor. The Federal Reserve said last week it expects the unemployment rate to climb from 4.3% to as much as 4.5% by the end of the year, but the latest data may allay some worries about further deterioration in the job market. “The mother lode of data just released suggest the economy is still doing just fine, despite the slowdown in employment growth,” wrote Alexandra Brown, North America economist for the market insight company Capital Economics, in a note to clients. The U.S. economy remains in a relatively precarious position. The latest GDP reading reflects the three months ending June 30, and the growth picture may have changed since then. A slowing labor market combined with President Donald Trump’s combination of aggressive tariffs and immigration enforcement has generated concerns about tepid growth. While consumer spending has remained resilient, there are growing warnings about a two tiered-economy in which lower- and middle-income people are squeezed as upper-income households continue to spend. Concerns about the job market spurred the Federal Reserve to take action this month, cutting interest rates in a bid to boost economic growth. There was some anticipation it would be the first of many.But Thursday’s positive economic data complicates the Fed’s situation.Following the morning’s data releases, investors dialed back the odds of additional cuts by the Federal Reserve this year. The Fed tends to cut when the economy is showing signs of slowing — and the new figures indicate there may be less of a need for lower interest rates to stimulate growth. “Thursday’s upward GDP revision for [the] second quarter confirmed that the economy grew at a healthy clip, even as tariff uncertainty reached fever pitch during the quarter,” Paul Stanley, chief investment officer of the Granite Bay Wealth Management financial group, said in a statement. “The U.S. economy is resilient and the strong GDP is another indication that we are not at risk of any kind of recession, even with slowing labor market growth.”But there are also concerns that growth is extremely uneven. A growing body of evidence suggests tech companies’ spending on artificial intelligence may almost single-handedly be propping up growth, especially as federal spending cuts and uncertainty over tariffs have clouded sentiment elsewhere. Commerce Department data show that in the first half of 2025, investment growth in equipment — a category that includes computers, electronics and power-supply parts — has been near records. “In the absence of tech-related spending, the US would be close to, or in, recession this year,” wrote George Saravelos, a head of research at the Deutsche Bank financial group. That’s not necessarily good news, he said: In order for tech to continue driving GDP growth, investments in AI, like building out data centers, needs to remain “parabolic.”“This is highly unlikely,” Saravelos said, given forecasts that such investment will likely peak this year.“Other sources of growth will have to take over,” he said. Rob WileRob Wile is a Pulitzer Prize-winning journalist covering breaking business stories for NBCNews.com.
September 22, 2025
Beijing promised to ‘fight back’ over Taiwan leader Tsai’s US visit. But this time it has more to lose
September 22, 2025
By Berkeley Lovelace Jr., Aria Bendix and Erika EdwardsPresident Donald Trump said Monday the Food and Drug Administration approved a chemotherapy drug called leucovorin as a treatment to alleviate symptoms of autism, despite little evidence that the medication works.Trump also said the administration is issuing a warning to doctors not to recommend acetaminophen — the active ingredient in Tylenol and other widely used medications — for pregnant women, claiming it may be linked to autism in children. Trump had been teasing the announcement for days, as Health Secretary Robert F. Kennedy Jr. and other health officials have pledged to determine the cause of the developmental disorder by September.The administration had planned to release its long-awaited report on causes of autism around Sept. 29 or Sept. 30, a person familiar with the matter told NBC News. But Trump pre-empted the rollout over the weekend, and details soon appeared in The Washington Post.“We understood a lot more than a lot of people who studied it,” Trump said from the White House, referring to autism. He spoke alongside Kennedy, Food and Drug Administration Commissioner Marty Makary, National Institutes of Health Director Jay Bhattacharya and Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services. ”Taking Tylenol is not good,” Trump said. “I’ll say it. It’s not good.”Leucovorin is a drug approved by the FDA to counteract the side effects of certain chemotherapy drugs and sometimes used off-label to treat vitamin B9 deficiency. Leucovorin is a form of folinic acid, a B vitamin. It has shown promise in clinical trials with helping some children with autism improve their speech. But the Autism Science Foundation, which funds evidence-based autism research, does not recommend it as a treatment yet and says more studies are needed.Trump said the FDA updated the drug’s label Monday for the treatment of autism symptoms. Oz said Medicaid — in partnership with states — will cover it with a prescription.“We believe insurance companies will rapidly follow our lead,” he said.Kennedy also said the FDA will issue a letter advising health care providers that the over-the-counter medication should be used during pregnancy only in cases of high fever, when the fever itself may pose a health risk to the fetus. The FDA’s notice, sometimes called a “Dear Doctor” letter, is meant to alert physicians and other prescribers about urgent or clinically significant safety issues it has identified with a drug. Kennedy also said the FDA will begin the process to initiate a safety label change for the drug.Bhattacharya said at Monday’s briefing that the NIH will dedicate $50 million to 13 research projects focused on identifying root causes and treatments for autism, an effort known as the “autism data science initiative.” The research will focus on environmental and medical factors, nutrition, events during pregnancy, biology and genetics, he said.“Given this wide range of symptoms across the spectrum, it seems certain that there will be a wide range of biological contributors to explaining the cause,” he said.Researchers who’ve spent decades researching potential causes of autism say the administration hasn’t uncovered any new evidence — and the existing data still doesn’t support its claims.“This is not new,” Dr. Allison Bryant, a high-risk obstetrician at Massachusetts General Hospital in Boston, said in an earlier interview. “It has bubbled up every now and again with studies that show maybe some kind of association but not clearly showing any cause and effect.”Experts say autism spectrum disorder, which is characterized by challenges with social and speech skills and by repetitive behaviors, most likely stems from multiple factors rather than a single cause. It affects 1 in 31 children in the United States, according to the Centers for Disease Control and Prevention.The bulk of scientific research hasn’t identified a link between acetaminophen and autism.“The science hasn’t changed regardless of what comes out from the report,” said Brian K. Lee, a professor of epidemiology at Drexel University in Philadelphia, referring to the Trump administration’s finding. “I’m not sure what the administration is doing, but it looks like they’re just going back and reviewing the evidence and they’re coming to a different conclusion than many scientists would.”Acetaminophen was introduced in the United States in the 1950s as a prescription alternative to aspirin. By the 1970s, it had been made available over the counter and became one of the most commonly used pain and fever medications in the country. The American College of Obstetricians and Gynecologists and other major medical groups say acetaminophen is one of the only safe pain relievers for women during pregnancy, and studies have shown no clear evidence that use during pregnancy leads to developmental issues in kids. The drug is also found in name brands like Theraflu and Excedrin.Forty percent to 65% of women use acetaminophen at some point during pregnancy, according to a 2014 study published in the American Family Physician.Earlier Monday, White House press secretary Karoline Leavitt touted a “major announcement” from Trump, telling reporters at a briefing to go into the autism announcement with “some critical thinking skills and with some open ears.”“They are paying attention to studies, and the gold standard of science and research, that many in this city for far too long have turned a blind eye to,” she said.Trump administration officials are citing previous research, including a literature review Mount Sinai and Harvard researchers published last month in the journal BMC Environmental Health. The review concluded there was most likely an association between autism and acetaminophen exposure during pregnancy. Outside autism researchers, however, said that the review wasn’t rigorously conducted and that it cherry-picked studies that supported its conclusion. The review’s senior author, Andrea Baccarelli, served in 2023 as a paid expert in a class action lawsuit against acetaminophen manufacturers, in which he testified that there was a link between the medication and autism. A judge ultimately excluded his testimony for being scientifically unsound and last year dismissed the case, which is being appealed.Baccarelli said in a statement that he and his colleagues conducted a rigorous review and that the association with neurodevelopmental disorders was strongest when acetaminophen was taken for four weeks or longer. He said he discussed his findings with Kennedy and Bhattacharya in recent weeks.“Further research is needed to confirm the association and determine causality, but based on existing evidence, I believe that caution about acetaminophen use during pregnancy — especially heavy or prolonged use — is warranted,” Baccarelli said.However, other autism researchers have pointed to a large study last year published in the Journal of the American Medical Association, which found no link between acetaminophen use in pregnancy and autism, ADHD or intellectual disability. The study, from Lee and his colleagues in Sweden, analyzed data from more than 2.4 million children. When the researchers looked solely at children with autism, there was a small increased risk possibly associated with acetaminophen. But when the researchers compared siblings within the same families — one exposed during pregnancy, the other not — the link disappeared. The comparison allowed them to control for variables that past studies couldn’t. Siblings share a large part of their genetic background and often have similar environmental exposures in utero and at home.“The biggest elephant in the room here is genetics,” Lee said. “We know that autism, ADHD and other neurodevelopmental disorders are highly heritable.”In an emailed statement, a spokesperson for Kenvue, the maker of Tylenol, said the drug is the safest pain reliever option for pregnant women.“Without it, women face dangerous choices: suffer through conditions like fever that are potentially harmful to both mom and baby or use riskier alternatives,” the spokesperson said. “We believe independent, sound science clearly shows that taking acetaminophen does not cause autism.”Bryant, of Massachusetts General Hospital, said, “The best science that we have available would still suggest that acetaminophen is a safe pain reliever and fever reducer in pregnancy.”Berkeley Lovelace Jr.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.Aria BendixAria Bendix is the breaking health reporter for NBC News Digital.Erika EdwardsErika Edwards is a health and medical news writer and reporter for NBC News and “TODAY.”
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved